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Abstract
Background: HIV/AIDS is a major public health concern in Uganda. There is widespread consensus that weak
health systems hamper the effective provision of HIV/AIDS services. In recent years, the ways in which HIV/AIDS-
focused programs interact with the delivery of other health services is often discussed, but the evidence as to
whether HIV/AIDS programs strengthen or distort overall health services is limited. The aim of this study was to
examine the effect of a PEPFAR-funded HIV/AIDS program on six government-run general clinics in Kampala.
Methods: Longitudinal information on the delivery of health services was collected at each clinic. Monthly changes in
the volume of HIV and non-HIV services were analyzed by using multilevel models to examine the effect of an HIV/AIDS
program on health service delivery. We also conducted a cross-sectional survey utilizing patient exit interviews to
compare perceptions of the experiences of patients receiving HIV care and those receiving non-HIV care.
Results: All HIV service indicators showed a positive change after the HIV program began. In particular, the
number of HIV lab tests (10.58, 95% Confidence Interval (C.I.): 5.92, 15.23) and the number of pregnant women
diagnosed with HIV tests (0.52, 95%C.I.: 0.15, 0.90) increased significantly after the introduction of the project. For
non-HIV/AIDS health services, TB lab tests (1.19, 95%C.I.: 0.25, 2.14) and diagnoses (0.34, 95%C.I.: 0.05, 0.64) increased
significantly. Noticeable increases in trends were identified in pediatric care, including immunization (52.43, 95%C.I.:
32.42, 74.43), malaria lab tests (1.21, 95%C.I.: 0.67, 1.75), malaria diagnoses (7.10, 95%C.I.: 0.73, 13.46), and skin
disease diagnoses (4.92, 95%C.I.: 2.19, 7.65). Patients’ overall impressions were positive in both the HIV and non-HIV
groups, with more than 90% responding favorably about their experiences.
Conclusions: This study shows that when a collaboration is established to strengthen existing health systems, in
addition to providing HIV/AIDS services in a setting in which other primary health care is being delivered, there are
positive effects not only on HIV/AIDS services, but also on many other essential services. There was no evidence
that the HIV program had any deleterious effects on health services offered at the clinics studied.
Background
HIV/AIDS in Uganda
HIV/AIDS has been a major cause of morbidity and mor-
t a l i t yi nU g a n d as i n c et h ed i s e a s ew a sf i r s td i a g n o s e di n
early 1980s [1]. Although Uganda is often cited as a coun-
try that successfully reduced the incidence and prevalence
of HIV/AIDS after peaking in the early 1990s [2][3], a
recent report suggests that the prevalence rose from 6.2%
in 1999/2000 to 7.7% in 2004/2005 in rural Uganda, and
the same study reports that the incidence has levelled off,
or has even shown signs of increasing [3,4]. In Uganda,
HIV/AIDS programs are funded primarily by Western
donors. The recent global economic downturn has also
affected the sustainability of these programs [5], has drawn
attention to the necessity of focusing more efforts on HIV/
AIDS and has resulted in more calls to increase support
from donor countries and global health initiatives (GHIs),
primarily the Global Fund to Fight AIDS, Tuberculosis
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AIDS Relief (PEPFAR) [6].
HIV/AIDS Programs and health systems
Although HIV/AIDS has been a critical concern in
many Sub-Saharan African countries including Uganda,
there is widespread consensus that weak health systems
hamper the effective provision of HIV/AIDS services.
To improve the health of people across low- and mid-
dle- income countries, the health system will have to be
addressed holistically [7,8]. In recent years, a number of
global health leaders and experts have highlighted how
HIV/AIDS-focused programs interact with other health
services that are not included in the more targeted HIV/
AIDS programs [9,10][11]. Some argue that concentrat-
i n ge f f o r t so nH I V / A I D Ss h o u l db ea b l et os t r e n g t h e n
health systems in general [12] by ensuring that qualified
health care workers are at clinics, enabling resources
allocated for HIV/AIDS to spill over to other health ser-
vices, and drawing attention to deficiencies in the health
system [13][14]. Others argue that a negative association
between HIV/AIDS programs and other services exists;
that the additional requirements of the HIV/AIDS pro-
grams disrupt basic health service delivery and overbur-
den a fragile health system [15]. However, there is little
evidence examining whether HIV/AIDS programs effec-
tively strengthen health services or divert resources
from other programs and distort overall health services
[14,16,17]. In particular, quantitatively interpretable stu-
dies that examine the interactions between delivery of
HIV/AIDS and non-HIV services have been very few,
and findings have been inconclusive [18-20].
We sought to examine the effect of a PEPFAR-funded
HIV/AIDS program on six local government-run, public,
urban clinics in Kampala Uganda. Herein we present an
analysis of the longitudinal trends of the variety of pri-
mary health care services provided at the six urban
clinics, including both HIV/AIDS and non-HIV/AIDS
services. Our purpose was to assess how the HIV/AIDS
project may have influenced HIV/AIDS services at the
clinics, as well as other primary health care services. In
addition to assessing the volume of services, the results
of exit interviews were conducted to explore client per-
ceptions of the care they received.
Methods
HIV/AIDS project background
Mulago-Mbarara Teaching Hospitals’ Joint AIDS Program
received funding from PEPFAR in May 2006 to support
six urban and peri-urban primary health clinics run by the
Kampala City Council (KCC) with the aim of providing
sustainable antiretroviral treatment (ART) through a part-
nership with the Infectious Diseases Institute (IDI) and
Makerere University College of Health Sciences
(MakCHS). IDI has expertise in treatment, training and
systems capacity building related to HIV/AIDS. Initially,
IDI was providing care for many of the patients served by
the KCC clinics. In order to decongest the Mulago Hospi-
tal Complex and, specifically, the IDI clinic, the IDI sought
funding to support HIV/AIDS program development and
care in the KCC clinics. IDI had no direct relationship
with the KCC or the clinics prior to the project. Another
key goal of the partnership was to enhance the responsive-
ness of IDI and MakCHS to the needs of the community
and key organizations in civil society. This project repre-
sented an opportunity to provide more coherent care to
the community, to build capacity and to forge meaningful
relationships with an important local stakeholder. Reflect-
ing this philosophy, the HIV/AIDS projects launched at
the six KCC clinics attempted to work through, and
improve, existing service delivery and administrative sys-
tems rather than set up parallel systems.
Study design and location
A longitudinal design was used for the analysis of health
services. More specifically, information on monthly
volumes of different health services was collected for the
12 months prior to the initiation of the HIV/AIDS pro-
grams until December, 2009 (up to 36 months of fol-
low-up for the clinics with the longest intervention
time). The primary health care services that had been
provided at these clinics included maternal and child
health services (e.g., childhood immunizations; acute
treatment of malaria, pneumonia, and diarrhea; antena-
tal care; family planning), tuberculosis testing and treat-
ment and other basic outpatient care.
The programs supported by the IDI included the fol-
lowing activities (see the study by Nankumbi et al. in
this issue for more details) [21]:
￿ Providing training and technical assistance for clinic
management through both classroom training and on-
site supervision and mentorship.
￿ Strengthening pharmacy management and technical
skills in addition to effecting physical space and organi-
zational improvements.
￿ Strengthening clinic management capacities to
monitor patients on ART, both clinically and through
lab-based diagnostics and testing.
￿ Providing procurement support for drugs and sup-
plies through training in supply chain management, pro-
vision of buffer stocks and transport facilitation.
￿ Providing laboratory support through physical
laboratory renovation and provision of new equipment.
￿ Ensuring that HIV testing and counseling are always
available through salary top-ups of staff and provision of
adequate supplies.
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and PMTCT (Prevention of Mother to Child Transmis-
sion) facilitated by Protecting Families against HIV/
AIDS (PREFA).
￿ Expanding TB screening and treatment through staff
training, provision of supplies and integration with HIV
care.
Six clinics (Komamboga, Kawal a ,K i s w a ,K i s e n y i ,K i r -
uddu, and Kitebi) received funding for these activities.
The clinics cover geographically distinct parts of urban
Kampala and serve different communities. The pro-
grams were introduced to the clinics at different times,
ranging from January 2006 at Kiswa to June 2008 at
Komamboga.
As part of the study, a cross-sectional survey utilizing
patient exit interviews was also conducted in July and
September 2009 in order to explore patient perceptions
of their experiences at the clinics. Patients were
recruited from the Kiswa, Kiruddu and Kisenyi clinics as
these had been receiving support from the IDI for the
longest period of time. To minimize disruption to the
clinics and delay to the patients, interviews were con-
ducted as exit interviews using pre-printed forms. As
such, consenting individuals were consecutively
recruited until the day’s target (or the end of the clinic
hours) was reached. Participants were recruited and
interviewed by IDI peer educators at each clinic. The
inclusion criteria for the patient survey were that an
individual was at least 18 years old, was able to consent
to take part, and that he or she had visited the clinic on
at least three separate occasions prior to the interview.
Interviews were conducted in either English or Luganda,
depending on the individual’s preference. The patient
sampling strategy was to ensure that a representative
sample of both HIV positive (both on ART and ART
naïve) and HIV negative patients from each clinic were
polled. General clinic and HIV clinic interviews were
conducted on different days, informed by the day(s) on
which the HIV clinic was held. The number of HIV-
positive patients, both on ART and ART naïve was
known, and 10% of the overall population of these
patients was sampled. However, the total number of
patients in non-HIV care at the clinics was not known.
Consequently, three non-HIV care patients were
sampled for every patient who was receiving HIV care.
Study instruments and dependent variables
The health service information was collected by utilizing
forms developed and used by the Ministry of Health for
the Health Management Information Systems (HMIS) to
avoid duplicate reporting and additional burdens on the
clinic staff [22]. The HMIS instrument was designed to
collect monthly data from individual clinics. The data
used for this study were compiled in December 2009.
The variables chosen for our study involve the following
categories of services:
￿ HIV health services, TB health services, Malaria
health services
￿ Maternal and Child Health (MCH)
￿ Family planning
￿ Diagnoses of dermatological problems
We selected “the number of patients provided with
contraceptive injections” as an indicator for family plan-
ning because this method of contraception is widely uti-
lized in Uganda [23], and it requires clinics to store the
pharmaceutical product and carry out an actual proce-
dure, both of which could be sacrificed if time or
resources of clinic staff were diverted because of HIV/
AIDS projects. The number of dermatological disease
cases was selected for both adults and children because
it was very common in the community in non-HIV
patients.
The patient interview questionnaire was developed
separately for this project. After voluntary consent was
obtained, patients who received HIV and non-HIV care
were asked questions with respect to their satisfaction
with the medical care and the medical providers. The
instrument was designed to assess patients’ clinic usage
and satisfaction with the specific services they had used.
The interview was designed to last no longer than
10 minutes. Informed by the project objectives and
existing patient satisfaction assessment tools [24], a
three-point Likert scale was used to assess patients’
agreement with a variety of statements related to their
treatment experience.
Analysis
The primary goal of the analysis was to estimate
changes in monthly health services volumes after the
program by the IDI was initiated. The null hypothesis
was that changes in the volume of non-focal health ser-
vices would have no relationship to the changes in HIV/
AIDS health service delivery. Alternatively, if health ser-
vices at the primary health care clinics were strength-
ened in a general way as a result of the project, then we
could expect there to be parallel increases in volume.
All the health service data were transferred from the
study instruments to Microsoft Excel (Microsoft Cor-
poration, Redmond, WA) and translated into STATA
format. Errors in each variable were checked by describ-
ing the range, identifying missing values and outliers
and using graphical descriptions such as histograms and
boxplots. After this process, project staff went back to
the clinics to correct any errors by examining the log-
books of clinic activities when these available. When a
variable was highly skewed or heavily tailed, data trans-
formation was used so that parametric statistical techni-
ques could be conducted smoothly.
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tion recorded every month at each clinic was in a clus-
tered and longitudinal format, violating the regression
assumption of the independence of observations. To
account for the non-independence of observations, as
well as to incorporate the inherent heterogeneity in dif-
ferent clinics, we developed a series of random coeffi-
cient models by using the STATA command xtmixed
[25,26]. A spline term was introduced to the time vari-
able to indicate the beginning of the project in order to
estimate the change in health service volumes before
and after the start of HIV/AIDS programs [27]. We spe-
cified the following random coefficient model to esti-
mate the trend in mean numbers of service volumes per
month at a typical clinic before and after the HIV pro-
gram began:
yij = (b1 + ς1j) + (b2 + ς2j)×timeij + b3×(timeij – time
when project began)
+ + εij
Here, yij is the estimated value of a service volume for
occasion i and clinic j; time indicates months from the
start of the observation; ς1j is a random intercept; ς2j is
a random coefficient; εij is the residual; b1 is an estimate
of the baseline volume of a health service; b2 is an esti-
mate of the change in the volume of a health service per
month before the HIV program; b3 is the coefficient for
the spline variable, representing the change in slope
from the previous period; and the sum of b2 + b3 is the
slope for the period after the HIV program began. Addi-
tional Poisson regression models were also tested in
under the assumption that the outcome data represent
counts, but the results do not change the inferences pre-
sented here.
For model visualization, clinic-specific predicted lines
for health services outputs were produced by using
empirical Bayes predictions. Categorical variables in
patient exit interviews are presented as frequencies (per-
centages), and the comparison was made with the use of
chi-square tests.
All statistical tests were two-sided and p<0.05 was
considered significant. All the analyses were conducted
by using STATA11.1 (StataCorp, Texas, USA).
Study approval
Approval for this study was obtained from the IDI
Scientific Review Committee, the Makerere University
Research and Ethics Committee, local IRB and the
Uganda National Council for Science and Technology.
Results
Table 1 shows baseline information on health services
delivery at the six KCC clinics when the HIV/AIDS pro-
grams by the IDI were rolled out for the first time.
Although overall attendance was similar across clinics,
there was a noticeable heterogeneity in baseline charac-
teristics. Notably low outputs in HIV services at Kiswa
indicate that KCC clinics had very little capacity to deli-
ver HIV services before 2006. Table 2 summarizes how
monthly trends in different health services changed after
the HIV programs were initiated. Figures 1, 2, 3, 4 illus-
trate the model-based fitted lines for key service indica-
tors at each clinic.
HIV service indicators
All variables in this category showed a positive change
after intervention by the IDI began. In particular, the
number of HIV lab tests increased significantly with the
introduction of the project (10.58, 95%C.I.: 5.92, 15.23)
and the number of pregnant women diagnosed with
HIV also showed a statistically significant increase (0.52,
95%C.I.: 0.15, 0.90). One of the key PMTCT indicators,
the number of women treated with anti-retroviral agents
(ARVs), did not show a significant change in its trend
with the project; however, the monthly output of this
s e r v i c ei n c r e a s e ds i g n i f i c a n t l ya f t e rt h ei n t e r v e n t i o n
(0.48, 95%C.I.: 0.21, 0.75).
Non-HIV/AIDS health service indicators
Most indicators across different services showed a signifi-
cant increase. First, TB lab tests (1.19, 95%C.I.: 0.25, 2.14)
and diagnoses (0.34, 95%C.I.: 0.05, 0.64) increased signifi-
cantly. This was probably attributable to direct interven-
tion by the IDI, since addressing TB-HIV co-infection was
one of the project goals. The second area of service that
showed a noticeable increase in the trend was pediatric
care, including immunization (52.43, 95%C.I.: 32.42,
74.43), lab tests for malaria (1.21, 95%C.I.: 0.67, 1.75),
malaria diagnoses (7.10, 95%C.I.: 0.73, 13.46) and skin dis-
ease diagnoses (4.92, 95%C.I.: 2.19, 7.65). Health services
that did not demonstrate a significant change between
before and after the project intervention were family plan-
ning, antenatal care and postnatal care.
Figures 1, 2, 3, 4 illustrate how HIV and TB indicators
showed positive change after the HIV programs were
launched. However, it also demonstrates a conspicuous
heterogeneity in the trend of health services outputs
across clinics after the beginning of the project, suggest-
ing that interactions between the HIV program and
other health services can vary among different clinics.
The figure includes a family planning indicator, “number
of injectable contraceptives provided,” as an example of
health services that did not show a change to the secular
trend, the trend prior to the intervention.
Patient exit survey and patients’ perceptions
A total of 2107 patients (774 at Kiruddu, 635 at Kisenyi,
698 at Kiswa) were interviewed, of whom 489 (23.2%)
were receiving antiretroviral treatment (ART). Table 3
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interviews to explore the perceptions of their experi-
ences. A comparison of the patients receiving HIV to
those not receiving HIV care revealed that, in general, a
greater proportion of the clients receiving HIV care
were likely to respond positively to questions on a three
point Likert scale (p<0.001). Overall, the proportion of
all patients who reported positive perceptions of clinic
care was high (more than 90% responding favorably
about their experiences).
Discussion
Using robust longitudinal techniques, our research demon-
strated that the KCC-IDI HIV/AIDS projects were able to
increase the volume of services provided for HIV, as well
as for many non-HIV health services that the project did
not specifically target. A significant positive change in
volume was identified in TB services, immunization ser-
vices and the malaria and dermatological services for
children. These projects also did not appear to have any
deleterious effect on any health services delivered at the
primary health care clinics in Kampala. In addition, HIV
patients showed that they were very satisfied with their
experiences at the clinics, and non-HIV patients were posi-
tive about the quality of care they received as well.
The way HIV/AIDS-focused programs interact with
delivery of other health programs has been discussed
intensely in recent years. Some researchers voiced con-
cerns about a negative impact of HIV programs on
human resources, suggesting that excessive focus on
rolling out ART could worsen health workforce con-
straints, and thereby undermine health systems [28,29].
In its evaluation of PEPFAR programs, the Institute of
Medicine stated that physical infrastructure, clinics,
laboratories, supply chain and information systems can
be stretched thin by the implementation of a national
HIV/AIDS program without careful planning [30]. Stu-
dies by McCoy and Druce suggest that expansion of
Table 1 Baseline number of health services provided in the month before the project started
Clinic
Komamboga Kawaala Kiswa Kisenyi Kiruddu Kitebi
Start of the HIV Project: Jun-08 Jun-07 Jan-06 Oct-07 Jan-07 Aug-07
Health Services
General
Total attendance 3162 2793 2453 2594 3761 4584
HIV Services
Number of HIV Lab tests 402 271 9 153 226 415
Number of HIV positive cases 39 44 1 20 44 76
Number of HIV positive cases put on co-trimoxazole prophylaxis 6 29 1 5 25 91
PMTCT service: Number of pregnant women positive for HIV 2 0 6 3 9 30
PMTCT Service: Number of HIV positive pregnant women given ARVs for treatment 0 0 2 0 9 2
Family Planning
Family Planning: Injectable Contraceptives 52 85 110 61 128 36
Maternal and Child Health
Total number of children immunized 1968 1412 451 794 1579 915
Total number of pregnant women immunized 167 189 114 126 302 70
MCH: antenatal care 75 224 88 100 197 424
MCH: postnatal care 6 72 1 2 41 13
Number of pregnancy tests 0 33 0 0 0 22
Malaria Services
Malaria lab tests: adults 58 120 522 196 483 54
Malaria lab tests: children 17 0 0 0 0 0
Malaria diagnosis: adults 698 803 681 1126 1450 766
Malaria diagnosis: children 447 363 334 300 875 293
Skin Diseases
Number of skin disease cases: adults 93 112 98 190 409 43
Number of skin disease cases: children 56 42 57 59 155 35
TB services
Number of TB lab tests 5 2 34 63 20 10
Number of TB diagnoses 0 1 5 29 10 15
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health care services, in particular, maternal and child
health care services [13,31].
However, most of these studies that have examined the
relationships between HIV and non-HIV services have not
been formally corroborated by statistically interpretable
analyses. Two studies that examined the association
between HIV and non-HIV services quantitatively should
be highlighted: Price and colleagues’ s t u d yi nR w a n d a[ 1 9 ] ;
and Walton and colleagues’ work in Haiti [18]. The
Rwanda study compared the aggregate quantities of health
services over six months at 30 primary health centers
before and after the introduction of basic HIV care and
revealed no deleterious change in the volume of primary
health services. The study showed a statistical increase not
only in the volume of pediatric care (including childhood
vaccinations), but also in reproductive health indicators
such as antenatal care visits. There are two reasons why
our study did not show the same result with respect to
antenatal care. First, the Rwandan government implemen-
ted a strong initiative to strengthen service delivery in
family planning, which probably caused the service volume
Table 2 Monthly trend in delivery of health services at a clinic level
Before
Intervention
After
Intervention
Change 95% C.I.* p value**
Health Services
General
Total attendance 27.62 38.08 10.46 (-25.73, 46.66) 0.571
HIV Services
Number of HIV Lab tests 7.16 17.74 10.58 (5.92, 15.23) <0.001
Number of HIV positive cases 1.66 2.32 0.66 (-0.54, 1.87) 0.283
Number of HIV positive cases put on Septrin prophylaxis 1.58 7.09 5.51 (-0.61, 11.63) 0.078
PMTCT service: Number of pregnant women positive for HIV 0.46 0.99 0.52 (0.15, 0.90) 0.007
PMTCT Service: Number of HIV positive pregnant women given ARVs
for treatment
0.36 0.48 0.12 (-0.20, 0.44) 0.476
Family Planning
Family Planning: Injectable Contraceptives -0.19 0.69 0.88 (-1.26, 3.02) 0.421
Maternal and Child Health
Total number of children immunized 1.69 55.12 53.43 (32.42, 74.43) <0.001
Total number of pregnant women immunized -0.64 9.69 10.33 (3.30, 17.35) 0.004
MCH: antenatal care 2.72 3.63 0.91 (-0.87, 2.68) 0.316
MCH: postnatal care 0.49 0.80 0.30 (-0.86, 1.47) 0.609
Number of pregnancy tests 0.23 2.22 1.99 (0.70, 3.29) 0.003
Malaria Services
Malaria lab tests: adults -1.82 0.57 2.39 (-3.19, 7.97) 0.401
Malaria lab tests: children 0.03 1.23 1.21 (0.67, 1.75) <0.001
Malaria diagnosis: adults -1.86 8.27 10.13 (-2.87, 23.13) 0.127
Malaria diagnosis: children 0.12 7.22 7.10 (0.73, 13.46) 0.029
Skin Diseases
Number of skin disease cases: adults 3.56 3.44 -0.13 (-3.54, 3.29) 0.941
Number of skin disease cases: children 1.00 5.92 4.92 (2.19, 7.65) <0.001
TB services
Number of TB lab tests 0.70 1.89 1.19 (0.25, 2.14) 0.013
Number of TB diagnoses -0.07 0.28 0.34 (0.05, 0.64) 0.023
Monthly Changes in Health Services Per Clinic.
*C.I.: Confidence Interval.
**Both 95% CI and p value were for the differences of monthly changes in health services outputs between before and after the start of the HIV programs,
estimated by random coefficient models.
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currently with the study. An equivalent initiative did not
occur in Uganda. Second, we performed a longitudinal
analysis to examine “changes” in the monthly trend of
health services, thereby isolating the effect of secular
change that would have occurred regardless of the intro-
duction of HIV programs. The methods used in the
Rwanda study did not allow for such separation of a secu-
lar change. This difference in the analytical methods made
our statistical estimates more conservative, but also more
robust. The Haitian study had many similarities to our
study, in that the HIV program was deliberately planned in
a way that allowed integration of HIV services into primary
health care. For example, their HIV program included
training and capacity building not only for HIV care, but
also for TB, STDs and women’s health. Utilization of the
primary health clinic, pre-natal care, and childhood vacci-
nations showed a large increase, although a statistical inter-
pretation was not provided by this study [18].
Exit surveys revealed that patients receiving both HIV
care and non-HIV care were largely positive about their
experiences. However, those receiving HIV care were
significantly more satisfied. Several reasons could explain
these findings. First, patients receiving HIV care might
have experienced more intensive interaction with medical
providers. Second, they might have felt a dramatically
positive effect on their health status as a result of the
start of HIV treatment. Another possibility is that
patients receiving HIV care were more likely to be repeat
users of the clinic who decided to return precisely
b e c a u s et h e yw e r es a t i s f i e dw i t ht h ec a r ea n dt h es t a f f ,
while those receiving non-HIV care were more likely to
be coming for urgent care. In that case, a selection bias
would be introduced to the cross-sectional sampling we
utilized, leading directly to the observed difference
between the two groups. Our study design could not
address these questions. Further research utilizing mixed
methods such as qualitative research and/or a cohort
design would be necessary to explore this topic.
This study provides stronger evidence that an HIV-
specific program, when deliberately planned to improve
broader health areas, can help to strengthen primary
health services more broadly. “Horizontal” elements of
our HIV project, including capacity building for the
Figure 1 Fitted trends for key health services. Graphs by Clinic.
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Figure 3 Fitted trends for key health services. Graphs by Clinic.
Matsubayashi et al. BMC International Health and Human Rights 2011, 11(Suppl 1):S9
http://www.biomedcentral.com/1472-698X/11/S1/S9
Page 8 of 11clinic staff, better supply chain management, strengthen-
ing of lab functions and infrastructure and improvement
in patient satisfaction are the potential mechanisms for
the positive trend in non-HIV services. In addition,
improvement of the clinic infrastructure attracted pro-
grams from other organizations such as Baylor
University and PREFA, which most likely contributed to
improving pediatric services. Nevertheless, our study
also highlighted the fact that automatic positive spillover
effect could not be expected, particularly in family plan-
ning and maternity health where no difference from the
secular trend was observed after intervention.
Figure 4 Fitted trends for key health services. Graphs by Clinic.
Table 3 Patients’ perceptions of clinic experiences
Receiving HIV
Care
Not receiving HIV
care
Total
Questions Asked Percent (95% C.I.) Percent (95% C.I.) Percent (95% C.I.) Pearson Chi
Statistic
Were you treated as an individual and
compassionately?
Yes 95.62 (94.18, 97.06) 86.95 (85.04, 88.87) 90.38 (89.07, 91.68) 41.42 (p<0.001)
Sometimes 2.84 (1.67, 4.00) 9.76 (8.07, 11.45) 7.03 (5.90, 8.16)
No 1.55 (0.68, 2.42) 3.28 (2.27, 4.30) 2.60 (1.89, 3.30)
Were you able to ask questions? Yes 94.47 (92.85, 96.08) 81.60 (79.39, 83.80) 86.68 (85.18, 88.18) 67.90 (p<0.001)
Sometimes 3.35 (2.08, 4.61) 12.44 (10.56, 14.31) 8.85 (7.59, 10.10)
No 2.19 (1.16, 3.22) 5.97 (4.62, 7.31) 4.47 (3.56, 5.39)
Do you trust skills and abilities of medical
providers?
Yes 97.15 (95.95, 98.36) 91.50 (89.86, 93.13) 93.75 (92.64, 94.85) 25.94 (p<0.001)
Somewhat 2.85 (1.64, 4.05) 7.52 (5.97, 9.07) 5.66 (4.61, 6.71)
No 0.00 0.98 (0.41, 1.57) 0.59 (0.24, 0.94)
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move effectively beyond its usual clinics and research
sites to enter into a collaboration with KCC, helping to
provide more coherent health services to its population
while building the systems of its partner. This approach
is consistent with the recent plans of the Makerere Col-
l e g eo fH e a l t hS c i e n c e st op l a yam o r ea c t i v er o l ei n
Ugandan society.
Several limitations to the interpretations of our study
need to be pointed out. First, it is not possible to deter-
mine a direct causality between the HIV program and
the increase in the volume of other health services, since
this is a retrospective study based on routinely collated
health center data. Conducting a randomized, controlled
study could better answer such a causality question;
however, withholding an HIV service at a facility or com-
munity level is neither possible nor ethical, and therefore
such an experimental study does not seem feasible. The
longitudinal analysis employed in our study allows the
strongest statistical inference for an observational study.
Second, the findings need to be considered in context in
order to evaluate their generalizability. Our project was
carried out in an urban area, which had better access to
supply and technical support than rural areas and many
other countries in Sub-Saharan Africa. The urbanization
of many sub-Saharan African countries make this urban
data interesting nonetheless. IDI has since rolled out
similar HIV programs in remote districts of Uganda with
a view to applying the success of its experiences in the
capital city. Future evaluation will answer the question of
how repeatable this approach is. Nevertheless, we pro-
pose that all carefully planned HIV programs include a
rigorous evaluation process not only for HIV-specific
indicators, but also for non-HIV service indicators and
contextual factors to conduct a valid program evaluation
[32]. Third, our study focused on the indicators at the
level of “outputs” instead of “outcome” and “impact”
[33]; therefore, we cannot tell whether improvement in
health service outputs catalyzed by an HIV program will
lead to better outcomes and/or impacts. In fact, one eco-
logical study that compared PEPFAR focus and non-
focus countries in the WHO Africa Region [20] identi-
fied no difference in overall health impact in a six-year
(2000 to 2006) period. Does this suggest that positive
synergies at the level of health services outputs are not
converted into actual improvement in health outcomes?
Our research does not address this question. Character-
istics of HIV programs have been changing from exces-
sively vertical approaches to broader programs that
increasingly recognize the importance of strengthening
health systems [34,35]. The outcome and impact of such
new approaches to HIV programs remain to be exam-
ined, and this is an area in which further research is
warranted.
Conclusions
This study shows that when a collaboration is estab-
lished to strengthen existing systems to provide HIV/
AIDS services in a setting where other primary health
care is also provided, there are positive effects not only
on HIV/AIDS services, but also on many other essential
services, including TB services, pediatric care for skin
diseases, immunization and malaria services. Although
the secular trend for the indicators in family planning
and reproductive health did not change, there was no
evidence that the HIV program deleteriously affected
any health services offered at the KCC clinics.
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